Visit "Ampyra Journeys"

Acorda Therapeutics Launches New Interactive Website Spotlighting Treatment with Ampyra® (Dalfampridine) Walking Problems in Patients with Multiple Sclerosis


HAWTHORNE, N.Y.--Acorda Therapeutics, Inc. (Nasdaq: ACOR) today announced the
launch of a new interactive patient website called Ampyra Journeys (www.AmpyraJourneys.com).

The site is the first-ever stand-alone patient site to focus on walking problems associated with multiple sclerosis (MS). Ampyra (dalfampridine) is an oral medication approved by the FDA as a treatment to improve walking in patients with multiple sclerosis. This was demonstrated by
an increase in walking speed.

The Ampyra Journeys website features true stories of people living with MS who have experienced walking problems and who took action to get treatment. Their stories explore the impact that walking problems can have for people living with MS, and how treatment that leads to improvements in walking can help people to regain the ability to perform many daily tasks.

Prominent MS patient advocate, motivational speaker and entertainer, Kristie Salerno Kent, is among the patients who share their personal stories on www.AmpyraJourneys.com.

“I have met so many people living with MS who did not seek help when they started to experience walking problems. The important news is that treatment is available, and so I am very excited to be involved with Ampyra Journeys. This new website is a vital resource that can help anyone living with MS to learn about, and to do something about, MS-related walking problems,” said Ms. Salerno Kent.

Walking problems are a significant concern for people living with MS. According to a 2011 Harris Interactive Survey, approximately 70% of people with MS who experience difficulty walking identify this issue as the biggest challenge associated with MS.

Visitors to www.AmpyraJourneys.com can also download “Let’s Talk About Walking and MS,” a guide with tips on how to talk about walking problems with a healthcare provider.

“Acorda Therapeutics developed Ampyra to help patients with walking problems, one of the most challenging and common symptoms of MS. Now we are very pleased to present Ampyra Journeys, to help more people get the support they need to get treatment. It's our hope that this site will educate and inspire people to seek help for their MS-related walking problems,” said Ron Cohen, MD, president and CEO of Acorda Therapeutics.



Click here to post comments

Join in and write your own page! It's easy to do. How? Simply click here to return to Do you have MS News? .

Privacy Policy ~ Advertising Policy ~ DisclaimerContact Us ~ About Us

SBI!